Public multi-state operator (MSO) Harvest Health & Recreation (CSE:HARV,OTCQX:HRVSF) will expand to 11 states with over 100 retail stores thanks to the acquisition of a private MSO.

On Monday (March 11), Harvest confirmed its US$850 million purchase of Verano Holdings through an all stock deal based on a share price of C$8.79.


The resulting corporation, if the deal is completed, will carry over 150 branded items for sale and hold 123 retail dispensaries in its portfolio, therefore allowing the company to operate in 16 total states

During a conference call with analysts and investors, the management of Harvest revealed beyond the number of states the company operates what is more significant to them is the “depth of reach within those states.”

When asked about upcoming markets that interest the company with this acquisition, the leaders of Harvest indicated New Jersey, Illinois and Nevada are some top markets to operate in.

Thanks to the purchase, Harvest gained entry to Illinois, New Jersey, Michigan, Oklahoma and Puerto Rico.

The management team of Harvest expects to see New Jersey and Illinois go ahead and open recreational sales in the next 12 months, adding more value to its purchase than previously anticipated due to key licenses in these states.

The acquisition will offer an overlap in the portfolio of licenses and presence in legal states.

“[The acquisition] supplements our operations and licenses in California, Nevada, Massachusetts, Ohio, Maryland and Arkansas,” Steve White, CEO of Harvest, said during the call.

Harvest was asked about the challenges of integrating the Florida assets from Verano due to policy rules on the ownership of multiple licenses by one party. White revealed Verano’s Florida interests were not being acquired as part of the whole transaction.

“We will do whatever we can to monetize it in the most strategic matter,” the executive said.

As part of the arrangement, investors of Veranos will obtain “a combination of Harvest subordinate voting shares and Harvest multiple voting shares as mutually agreed between the parties.”

Harvest expects the acquisition to be completed in the first half of 2019.

“We have the unique opportunity to create truly national brands by deploying these products within the future combined footprint of states and dispensaries,” Steve White, CEO of Harvest, said in a press release.

Shares of Harvest jumped during Monday’s trading session thanks to the announcement. The stock rose 10.59 percent to close the day at a price of C$9.50 per share.

Over a year-to-date period, shares of Harvest have increased in value by 21.16 percent, representing a C$1.50 gain.

“Within the next 18 months, Harvest plans to cultivate more than 720,000 [square feet] of indoor, outdoor and greenhouse cannabis,” an info document prepared by Canaccord Genuity (TSX:CF) as part of this year’s “Growth Investor Day.”

In February, Matt Bottomley, cannabis analyst for Canaccord, raised his price target on the MSO to C$16 and retained his “Speculative Buy” rating for the stock.

Similarly, Nawan Butt, portfolio manager with Purpose Investments, and Alan Brochstein, cannabis analyst with 420 Investor, signaled the stock as one of the ones to watch in the growing MSO space.

Harvest was highlighted as one of the “significant investment banking transactions” for the financial institution during its fiscal Q3 for 2019.

Harvest reached a listing on the Canadian Securities Exchange (CSE) in November, through a raise reported by Reuters to be worth C$303 million.

During the conference call, Harvest revealed talks with Verano picked up last summer were put on hold as the company needed to complete its reverse-takeover deal.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in contributed article. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.

 Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) announces that Philip Young, CEO and Director, and Maghsoud Dariani, Chief Science Officer will be presenting on Thursday, February 25th, 2021 at 5:45 pm EST at “The Gold Standard in Psychedelic Investment, Psychedelic Capital Virtual Investment Conference”, a platform showcasing the top companies, latest IPOs, newest opportunities, and deepest industry insights.

As a presenting sponsor, the Company will connect directly with some of the earliest moving investors in the psychedelic industry and reach an audience of 2,000+ investors. Presentations are 30 minutes in length, with 10 minutes allocated to a one-on-one Q&A session with the audience.

Keep reading... Show less

As Canadian operators race to strengthen their positions in the cannabis landscape, are international pursuits outside North America still top of mind?

The role that mergers and acquisitions (M&A) have played in the expansion of Canadian companies across the globe has been monumental for the growth of the cannabis industry. Now the space has reached a critical point as the demands of the US market increase.

Keep reading... Show less

It’s been just over a year since recreational cannabis was legalised in the Australian Capital Territory (ACT), home to the nation’s capital city of Canberra.

Announced on September 25, 2019, and brought into effect on January 31, 2020, the rules make it legal to possess and personally use small amounts of cannabis.

Keep reading... Show less

Pac Roots Cannabis Corp. (CSE: PACR) (“PacRoots” or the “Company”), announces the closing of its previously announced non-brokered private placement (see press release dated January 25, 2021).

Aggregate gross proceeds of $1,340,685.90 were raised through the issuance of 7,448,255 units (each a “Unit”). Each Unit consists of one common shares and one share purchase warrant. Each warrant is exercisable at a price of $0.30 per share until February 23, 2024.

Keep reading... Show less

 Trulieve Cannabis Corp. (“Trulieve” or the “Company”) (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States will release its fourth quarter 2020 financial results on Tuesday, March 23, 2021 before markets open. Following the earnings release, management will host a conference call at 8:30 AM Eastern Time to review the financial results.

All interested parties can join the conference call by dialing 1-888-231-8191 or 1-647-427-7450, conference ID: 7066881. Please dial in 15 minutes prior to the call to secure a line. The conference call will be archived for replay until March 30, 2021 . To access the archived conference call, please dial 1-855-859-2056 and enter the encore code 7066881.

Keep reading... Show less